KLL tedavisinde Target druglar
1-Venetoclax ( Bcl-2 inhibitorü),
2-İbrutinib ( Bruton’s tyrosine kinase inhibitorü),
3-İdelalisib ve duvelisib (phosphoinositide 3-kinase inhibitorü),
KLL tedavisinde monoclonal antibodies against
1-CD20 (rituximab, ofatumumab ve obinutuzumab)
2-CD52 (alemtuzumab)
